SPRY vs TLRY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
SPRY exhibits severe financial distress as evidenced by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. Despite a strong liquidity position (Current Ratio 7.28), the company is facing a catastrophic revenue collapse of -67.60% YoY and deep negative profit margins of -203.25%. There is a stark divergence between the 'Strong Buy' analyst consensus and the actual data, which shows bearish insider selling and a 0/100 technical trend. The valuation remains speculative and disconnected from current operational performance.
Tilray Brands exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating a company in financial distress. The firm suffers from catastrophic profitability metrics, including a profit margin of -156.66% and a total failure to beat earnings estimates in the last four quarters (0/4). While a strong current ratio of 2.79 provides a temporary liquidity buffer, the long-term trajectory is characterized by massive value destruction, with a 5-year price decline of 95.8%. The disconnect between the 'Buy' analyst consensus and the deterministic health scores suggests the stock is being traded on speculative regulatory hopes rather than operational performance.
Compare Another Pair
Related Comparisons
SPRY vs TLRY: Head-to-Head Comparison
This page compares ARS Pharmaceuticals, Inc. (SPRY) and Tilray Brands, Inc. (TLRY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.